Conmed Corporation ( (CNMD) ) has released its Q4 earnings. Here is a breakdown of the information Conmed Corporation presented to its investors.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
CONMED Corporation is a medical technology company that provides devices and equipment for surgical procedures across various specialties including orthopedics and general surgery.
In its latest earnings report, CONMED Corporation reported significant financial growth for the fourth quarter and full-year 2024, showcasing resilience despite ongoing supply challenges. The company observed an increase in both domestic and international revenues.
For the fourth quarter of 2024, CONMED Corporation achieved sales of $345.9 million, marking a 5.8% increase year-over-year. The company saw a rise in domestic revenue by 6.8% and international revenue by 4.4%. Furthermore, the adjusted diluted net earnings per share rose significantly by 26.4% compared to the same period in 2023. For the full year 2024, the company reported a 5.0% increase in sales, with domestic and international revenues up by 6.9% and 2.6%, respectively. The diluted net earnings per share also saw a dramatic rise from $2.04 in 2023 to $4.25 in 2024.
CONMED’s management expressed satisfaction with the improved profitability achieved in 2024 and emphasized their focus on operational improvements and foundation strengthening for 2025. The company projects a continued revenue growth of 4% to 6% for the upcoming year, maintaining its focus on overcoming currency headwinds and other external challenges.
Looking ahead, CONMED Corporation expects to sustain its growth trajectory with anticipated revenues between $1.344 billion and $1.372 billion for 2025. The company remains committed to enhancing its operations and profitability, aiming to achieve above-market growth amidst prevailing market conditions.
